RhemaStem, a biotech company specialising in the research and development of innovative drugs for colorectal cancer and other solid cancers. We provide an advanced and unique platform technology to address critical shortcomings in existing methods of isolation and production of tumour and normal stem cells for drug discovery and development.
Our goal? To cure colorectal cancer and other solid cancers with our unique expertise and skills in the field of cancer and normal stem cells – an approach we champion with unwavering conviction.
RhemaStem also offers consulting services in the area of solid cancer stem cells, encompassing colon, lung, breast, prostate, ovary, brain, circulating blood cells, and other cancers.
Company Details
- Address
- Via Passerini 2, Monza,italy 20900,italy
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://rhemastem.com/
- HQ
- Monza, Italy
Rhemastem Srls Questions
Rhemastem Srls's website is https://rhemastem.com/
Rhemastem Srls's LinkedIn profile is https://it.linkedin.com/company/rhemastem-srls
Rhemastem Srls's industry is
Biotechnology Research
Rhemastem Srls's top competitors are
Synchrony,
St Innovative Diagnostics Ltd.,
Geneta Srl,
Mitophilix,
Epigenetic Data Sciences,
Chess Therapeutics, Llc,
Metimedi Co., Ltd.,
Seal Biosciences,
Lymphact,
St-Diagnostic.
Rhemastem Srls's categories are Biotechnology Research
